Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial
Related Posts
Chitsazan M, Parekh JK, Grundmann AL, Lau ES, Alotaibi M, Yu B, Rebholz CM, Selvin E, Allen NB, Allison MA, Jain M, Cheng S, Ho[...]
Echouffo-Tcheugui JB, Liu X, Soliman EZ, Pi-Sunyer X, Golden SH, Dagogo-Jack S, White NH, Budoff M, Ibebuogu U, Darwin C, Knowler WC, Temprosa M; DPP[...]
Brownell NK, Inkelas M, Chen L, Leng M, Doan AAQ, Shannon E, Jackson N, Hsue P, Ong M, Yano E, Fonarow GC, Ziaeian B. Healthcare[...]